Avoiding methodological bias in studies of amyloid imaging results disclosure.
作者信息
Taswell Carl, Donohue Cheryl, Mastwyk Maree T, Louey Andrea G, Giummarra Jacqueline, Robertson Joanne, Darby David G, Masters Colin L, Rowe Christopher C
机构信息
Brain Health Alliance, Ladera Ranch, CA, USA.
Department Psychiatry, University California San Diego, La Jolla, CA, USA.
出版信息
Alzheimers Res Ther. 2019 Jun 4;11(1):52. doi: 10.1186/s13195-019-0495-y.
Abstract
摘要
相似文献
1
Avoiding methodological bias in studies of amyloid imaging results disclosure.避免淀粉样蛋白成像结果披露研究中的方法学偏倚。
Alzheimers Res Ther. 2019 Jun 4;11(1):52. doi: 10.1186/s13195-019-0495-y.
2
Response to "Avoiding Methodological Bias in Studies of Amyloid Imaging Results Disclosure".对《避免淀粉样蛋白成像结果披露研究中的方法学偏差》的回应
Alzheimers Res Ther. 2019 Jun 4;11(1):51. doi: 10.1186/s13195-019-0504-1.
3
Disclosure of positron emission tomography amyloid imaging results: A preliminary study of safety and tolerability.正电子发射断层扫描淀粉样蛋白成像结果的披露：安全性和耐受性的初步研究。
Alzheimers Dement. 2016 Apr;12(4):454-8. doi: 10.1016/j.jalz.2015.09.005. Epub 2015 Dec 30.
4
PET Amyloid Analyses.正电子发射断层扫描淀粉样蛋白分析
J Nucl Med. 2016 Aug;57(8):1168-9. doi: 10.2967/jnumed.116.173989. Epub 2016 Apr 14.
5
Reconsidering and Reforming the Amyloid Cascade Hypothesis.重新审视和改革淀粉样蛋白级联假说
Curr Protein Pept Sci. 2021;22(6):449-457. doi: 10.2174/1389203722666210322151627.
6
Generic inhibition of amyloidogenic proteins by two naphthoquinone-tryptophan hybrid molecules.两种萘醌-色氨酸杂合分子对淀粉样蛋白原的普遍抑制作用。
Proteins. 2012 Aug;80(8):1962-73. doi: 10.1002/prot.24080. Epub 2012 May 26.
7
How our bodies fight amyloidosis: effects of physiological factors on pathogenic aggregation of amyloidogenic proteins.我们的身体如何对抗淀粉样变性：生理因素对淀粉样蛋白致病性聚集的影响。
Arch Biochem Biophys. 2015 Feb 15;568:46-55. doi: 10.1016/j.abb.2015.01.007. Epub 2015 Jan 20.
8
Mutated tau, amyloid and neuroinflammation in Alzheimer disease-A brief review.阿尔茨海默病中的突变tau蛋白、淀粉样蛋白与神经炎症——简要综述
Prog Histochem Cytochem. 2016 May;51(1):1-8. doi: 10.1016/j.proghi.2016.01.001. Epub 2016 Jan 16.
9
β-Amyloid Accumulation Slows Earlier than Expected in Preclinical Alzheimer's Disease Patients.在临床前阿尔茨海默病患者中，β-淀粉样蛋白的积累比预期更早减缓。
J Neurosci. 2018 Oct 24;38(43):9123-9125. doi: 10.1523/JNEUROSCI.1592-18.2018.
10
Anti-amyloid therapies for Alzheimer disease: finally, good news for patients.用于治疗阿尔茨海默病的抗淀粉样蛋白疗法：终于，给患者带来了好消息。
Mol Neurodegener. 2023 Jun 28;18(1):42. doi: 10.1186/s13024-023-00637-0.
引用本文的文献
1
Response to "Avoiding Methodological Bias in Studies of Amyloid Imaging Results Disclosure".对《避免淀粉样蛋白成像结果披露研究中的方法学偏差》的回应
Alzheimers Res Ther. 2019 Jun 4;11(1):51. doi: 10.1186/s13195-019-0504-1.
本文引用的文献
1
Reactions to learning a "not elevated" amyloid PET result in a preclinical Alzheimer's disease trial.在一项临床前阿尔茨海默病试验中，学习到“不升高”淀粉样蛋白 PET 结果的反应。
Alzheimers Res Ther. 2018 Dec 22;10(1):125. doi: 10.1186/s13195-018-0452-1.
2
Outcome reporting bias in trials: a methodological approach for assessment and adjustment in systematic reviews.试验中的结局报告偏倚：系统评价中评估和调整的方法学途径。
BMJ. 2018 Sep 28;362:k3802. doi: 10.1136/bmj.k3802.
3
The psychological impact of disclosing amyloid status to Japanese elderly: a preliminary study on asymptomatic patients with subjective cognitive decline.向日本老年人披露淀粉样蛋白状态的心理影响：对有主观认知下降但无症状的患者的初步研究。
Int Psychogeriatr. 2018 May;30(5):635-639. doi: 10.1017/S1041610217002204. Epub 2017 Nov 2.
4
Guidelines for reporting methodological challenges and evaluating potential bias in dementia research.痴呆症研究中报告方法学挑战及评估潜在偏倚的指南。
Alzheimers Dement. 2015 Sep;11(9):1098-109. doi: 10.1016/j.jalz.2015.06.1885.
5
Issues of validity and reliability in qualitative research.定性研究中的效度和信度问题。
Evid Based Nurs. 2015 Apr;18(2):34-5. doi: 10.1136/eb-2015-102054. Epub 2015 Feb 4.
6
Observer bias in randomized clinical trials with measurement scale outcomes: a systematic review of trials with both blinded and nonblinded assessors.在具有测量量表结局的随机临床试验中存在观察者偏倚：对具有盲法和非盲法评估者的试验进行的系统评价。
CMAJ. 2013 Mar 5;185(4):E201-11. doi: 10.1503/cmaj.120744. Epub 2013 Jan 28.
7
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials.Cochrane 协作网评估随机试验偏倚风险的工具。
BMJ. 2011 Oct 18;343:d5928. doi: 10.1136/bmj.d5928.
8
Frequency and reasons for outcome reporting bias in clinical trials: interviews with trialists.临床试验中结局报告偏倚的频率和原因：试验者访谈。
BMJ. 2011 Jan 6;342:c7153. doi: 10.1136/bmj.c7153.
9
Twenty suicide assessment instruments: evaluation and recommendations.
Death Stud. 1997 Jan-Feb;21(1):25-58. doi: 10.1080/074811897202128.
10
Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials.偏倚的实证证据。与对照试验中治疗效果估计相关的方法学质量维度。
JAMA. 1995 Feb 1;273(5):408-12. doi: 10.1001/jama.273.5.408.
Zotero 插件